Newsflash:
- Many Drug Labels Missing Dose, Safety Info for Kids
- Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer
- J&J Opens Doxil Rationing Program to New Patients
- FDA Issues Safety Label Changes for Fingolimod
- FDA Backs Pill to Block HIV Infection
- FDA Advisers Recommend Approving Arena Weight-Loss Drug
Nearly 300 Drugs for Children Under Development in USA
thepharmaletter.com (01/15/2012)
U.S. biopharmaceutical companies are researching 282 medicines to help meet the unique health care needs of children and adolescents, according to a new report released by the Pharmaceutical Research and Manufacturers of America. The medicines are currently in clinical trials or under review by the FDA.
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
